The antisense homology box: A new motif within proteins that encodes biologically active peptides

Amphiphilic peptides approximately fifteen amino acids in length and their corresponding antisense peptides exist within protein molecules. These regions (termed antisense homology boxes) are separated by approximately fifty amino acids. Because many sense–antisense peptide pairs have been reported to recognize and bind to each other, antisense homology boxes may be involved in folding, chaperoning and oligomer formation of proteins. The antisense homology box–derived peptide CALSVDRYRAVASW, a fragment of human endothelin A receptor, proved to be a specific inhibitor of endothelin peptide (ET–1) in a smooth muscle relaxation assay. The peptide was able to block endotoxin–induced shock in rats as well. Our finding of endothelin receptor inhibitor among antisense homology box–derived peptides indicates that searching proteins for this new motif may be useful in finding biologically active peptides.

[1]  K. Bost,et al.  Similarity between the corticotropin (ACTH) receptor and a peptide encoded by an RNA that is complementary to ACTH mRNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Nakanishi,et al.  Cloning and expression of a cDNA encoding an endothelin receptor , 1990, Nature.

[3]  R. Parthasarathy,et al.  A model for hydropathy-based peptide interactions. , 1989, Archives of biochemistry and biophysics.

[4]  Y. Shai,et al.  Antisense peptide recognition of sense peptides: sequence simplification and evaluation of forces underlying the interaction. , 1989, Biochemistry.

[5]  A Tropsha,et al.  Making sense from antisense: A review of experimental data and developing ideas on sense–antisense peptide recognition , 1992, Journal of molecular recognition : JMR.

[6]  A. Moffat Making sense of antisense. , 1991, Science.

[7]  K. Bost,et al.  Antibodies to the binding site of the receptor for luteinizing hormone-releasing hormone (LHRH): generation with a synthetic decapeptide encoded by an RNA complementary to LHRH mRNA. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Webb,et al.  Endothelin: progress in pharmacology and physiology. , 1993, Trends in pharmacological sciences.

[9]  Blalock Je Complementarity of peptides specified by «sense» and «antisense» strands of DNA , 1990 .

[10]  V. Mooser,et al.  Vasopressin antisense peptide interactions with the V1 receptor , 1990, Peptides.

[11]  K. Bost,et al.  Production of anti‐idiotypic antibodies by immunization with a pair of complementary peptides , 1989, Journal of molecular recognition : JMR.

[12]  R. Brentani,et al.  Characterization of the cellular receptor for fibronectin through a hydropathic complementarity approach. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. Moore,et al.  Angiotensin 'antipeptides': (-)messenger RNA complementary to human angiotensin II (+)messenger RNA encodes an angiotensin receptor antagonist. , 1989, Biochemical and biophysical research communications.

[14]  J. Blalock,et al.  Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[15]  K. Bost,et al.  An antibody to a peptide specified by an RNA that is complementary to γ-endorphin mRNA recognizes an opiate receptor , 1986, Journal of Neuroimmunology.

[16]  A D Olson,et al.  Recognition properties of peptides hydropathically complementary to residues 356-375 of the c-raf protein. , 1989, The Journal of biological chemistry.

[17]  Brenda L. Bass,et al.  A developmentally regulated activity that unwinds RNA duplexes , 1987, Cell.

[18]  H. Johnson,et al.  A novel arginine vasopressin-binding peptide that blocks arginine vasopressin modulation of immune function. , 1988, Journal of Immunology.

[19]  M. Sokolovsky Endothelins and sarafotoxins: receptor heterogeneity. , 1994, The International journal of biochemistry.

[20]  A. Doherty,et al.  Endothelin and structurally related analogs distinguish between endothelin receptor subtypes. , 1992, Biochemical and biophysical research communications.

[21]  W. Neidhart,et al.  Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist , 1993, Nature.

[22]  S. Siegel,et al.  Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.

[23]  R. Brentani,et al.  Determination of the putative binding site for fibronectin on platelet glycoprotein IIb-IIIa complex through a hydropathic complementarity approach. , 1989, The Journal of biological chemistry.

[24]  A. Eberle,et al.  Antisense peptides: tools for receptor isolation? Lack of antisense MSH and ACTH to interact with their sense peptides and to induce receptor-specific antibodies. , 1991, Journal of receptor research.

[25]  K. Nakao,et al.  Distinct subdomains of human endothelin receptors determine their selectivity to endothelinA-selective antagonist and endothelinB-selective agonists. , 1993, The Journal of biological chemistry.

[26]  K. Draper Self-complementary regions in human albumin mRNA encode important structural regions within the human albumin protein. , 1989, Biochemical and biophysical research communications.

[27]  V. Castronovo,et al.  Laminin receptor complementary DNA-deduced synthetic peptide inhibits cancer cell attachment to endothelium. , 1991, Cancer research.

[28]  D. Melton,et al.  Antisense RNA injections in fertilized frog eggs reveal an RNA duplex unwinding activity , 1987, Cell.

[29]  J. Grassi,et al.  Antipeptide Polyclonal Antibodies that Recognize a Substance P‐Binding Site in Mammalian Tissues: A Biochemical and Immunocytochemical Study , 1994, Journal of neurochemistry.

[30]  G. Fassina,et al.  Design of hydropathically complementary peptides for Big Endothelin affinity purification. , 2009, International journal of peptide and protein research.

[31]  E. Benveniste,et al.  Monoclonal idiotypic and anti-idiotypic antibodies produced by immunization with peptides specified by a region of human myelin basic protein mRNA and its complement , 1989, Journal of Neuroimmunology.

[32]  The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa. , 1991, Biochemical and biophysical research communications.

[33]  K. Ebner,et al.  Interactions of antisense peptides with ovine prolactin. , 1991, Biochemical and biophysical research communications.

[34]  H. Morris,et al.  Mass spectrometry of natural and recombinant proteins and glycoproteins , 1988 .

[35]  V. P. Knutson Insulin-binding peptide. Design and characterization. , 1988, Journal of Biological Chemistry.

[36]  D. Brutlag,et al.  Is there a relationship between DNA sequences encoding peptide ligands and their receptors? , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[37]  V. Kon,et al.  Endothelin and cyclosporine nephrotoxicity. , 1992, Renal failure.

[38]  T. Sakurai,et al.  Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor , 1990, Nature.

[39]  Y. Yazaki,et al.  Production of endothelin-1 in vascular endothelial cells is regulated by factors associated with vascular injury. , 1992, Gerontology.

[40]  J. Zull,et al.  Is genetic code redundancy related to retention of structural information in both DNA strands? , 1990, Trends in biochemical sciences.

[41]  K. P. Murphy,et al.  Molecular basis of co-operativity in protein folding. , 1992, Journal of molecular biology.

[42]  R. Seckler,et al.  Protein folding and protein refolding , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  K. Bost,et al.  Regions of complementarity between the messenger RNAs for epidermal growth factor, transferrin, interleukin-2 and their respective receptors. , 1985, Biochemical and biophysical research communications.

[44]  U. Rasmussen,et al.  On antisense peptides: the parathyroid hormone as an experimental example and a critical theoretical view. , 1987, Biochemical and biophysical research communications.

[45]  J. Whitaker,et al.  Specific modulation of T cells and murine experimental allergic encephalomyelitis by monoclonal anti-idiotypic antibodies. , 1993, Journal of immunology.

[46]  N. Aiyar,et al.  Affinity capture of [Arg8]vasopressin-receptor complex using immobilized antisense peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[47]  K. Bost,et al.  Monoclonal antibody against a peptide specified by [Met]-enkephalin complementary RNA recognizes the delta-class opioid receptor. , 1989, Immunology letters.

[48]  M. Zamai,et al.  Sequence-directed recognition peptides: inhibition of endothelin generation via a substrate-depletion mechanism. , 1993, Biochimica et biophysica acta.

[49]  E. M. Smith,et al.  Hydropathic anti-complementarity of amino acids based on the genetic code. , 1984, Biochemical and biophysical research communications.

[50]  S. Whitebread,et al.  Are the antibodies to a peptide complementary to angiotensin II useful to isolate the angiotensin II receptor? , 1989, The Biochemical journal.

[51]  J. Blalock,et al.  Characterization and localization of mosquito‐gut receptors for trypsin modulating oostatic factor using a complementary peptide and immunocytochemistry , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  T. K. Gartner,et al.  The Peptide Glu-His-IIe-Pro-Ala Binds Fibrinogen and Inhibits Platelet Aggregation and Adhesion to Fibrinogen and Vitronectin , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[53]  E. Escher,et al.  The peptide encoded by angiotensin II complementary RNA does not interfere with angiotensin II action. , 1989, The Biochemical journal.

[54]  K. Bost,et al.  Immunoaffinity‐purified opiate receptor specifically binds the δ‐class opiate receptor ligand, cis‐(+)‐3‐methylfentanylisothiocyanate, SUPERFIT , 1987, FEBS letters.

[55]  E. Kaiser,et al.  Secondary structures of proteins and peptides in amphiphilic environments. (A review). , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[56]  M. Campbell-Thompson,et al.  Complementary peptide to the carboxyl-terminal tetrapeptide of gastrin. , 1992, Gastroenterology.

[57]  S. Oparil,et al.  Purification of an angiotensin II binding protein by using antibodies to a peptide encoded by angiotensin II complementary RNA. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[58]  L. V. von Segesser,et al.  Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. , 1994, Circulation.

[59]  W. Reiher,et al.  The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor. , 1986, Biochemical and biophysical research communications.

[60]  Y. Liu,et al.  A novel acetylcholine receptor-related peptide blocks canine cardiac ganglia and inhibits the nicotinic receptor of PC-12 cells. , 1992, Journal of the autonomic nervous system.

[61]  G. Viscomi,et al.  Purification of recombinant human interferon-β by immobilized antisense peptides , 1992 .

[62]  P. Y. Chou,et al.  Conformational parameters for amino acids in helical, beta-sheet, and random coil regions calculated from proteins. , 1974, Biochemistry.

[63]  S. Thorgeirsson,et al.  Sequence Directed Design of Recognition Peptides , 1989 .

[64]  J. Leoni,et al.  Binding of cystatin C to C4: the importance of sense-antisense peptides in their interaction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[65]  M. Campbell-Thompson,et al.  Canine parietal cell binding by antibodies to the complementary peptide of somatostatin. , 1993, The American journal of the medical sciences.

[66]  J. Blalock,et al.  Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide. , 1988, Science.